EVM14 received U.S. FDA clearance for its IND application, becoming Everest's first internally discovered program, and the first mRNA therapeutic cancer vaccine to be cleared for global clinical development. Preclinical highlights： EVM14 induced a dose-dependent, antigen-specific immune...
Read More Details
Finally We wish PressBee provided you with enough information of ( Everest Medicines Announces FDA Clearance of IND Application for Tumor-Associated Antigen Vaccine EVM14 )
Also on site :
- Authorities investigate after 8 injured in Colorado attack by man they say yelled ‘Free Palestine’
- Country Icon, 63, Cancels Show at Last Minute Amid Health Issues, Leaving Fans Irate
- Meta wants to replace its human workers with AI to review privacy and societal risks